ICCC

ImmuCell (ICCC)

ImmuCell Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ICCC

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	05:50	Edgar (US Regulatory)	Form SCHEDULE 13D - General statement of acquisition of beneficial ownership	NASDAQ:ICCC	ImmuCell Corporation
2024/05/15	05:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ICCC	ImmuCell Corporation
2024/05/15	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICCC	ImmuCell Corporation
2024/05/15	05:05	GlobeNewswire Inc.	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024	NASDAQ:ICCC	ImmuCell Corporation
2024/05/09	02:00	GlobeNewswire Inc.	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024	NASDAQ:ICCC	ImmuCell Corporation
2024/04/10	05:05	GlobeNewswire Inc.	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024	NASDAQ:ICCC	ImmuCell Corporation
2024/03/07	03:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICCC	ImmuCell Corporation
2024/02/28	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICCC	ImmuCell Corporation
2024/02/28	06:05	GlobeNewswire Inc.	ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023	NASDAQ:ICCC	ImmuCell Corporation
2024/02/16	23:30	GlobeNewswire Inc.	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023	NASDAQ:ICCC	ImmuCell Corporation
2024/01/09	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICCC	ImmuCell Corporation
2024/01/09	06:05	GlobeNewswire Inc.	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023	NASDAQ:ICCC	ImmuCell Corporation
2023/11/17	05:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICCC	ImmuCell Corporation
2023/11/14	06:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ICCC	ImmuCell Corporation
2023/11/14	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICCC	ImmuCell Corporation
2023/11/14	06:05	GlobeNewswire Inc.	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023	NASDAQ:ICCC	ImmuCell Corporation
2023/11/08	02:15	GlobeNewswire Inc.	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023	NASDAQ:ICCC	ImmuCell Corporation
2023/10/06	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICCC	ImmuCell Corporation
2023/10/06	05:05	GlobeNewswire Inc.	ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023	NASDAQ:ICCC	ImmuCell Corporation
2023/09/07	01:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ICCC	ImmuCell Corporation
2023/08/31	03:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ICCC	ImmuCell Corporation
2023/08/29	21:00	GlobeNewswire Inc.	ImmuCell Announces Submission of CMC Technical Section to the FDA	NASDAQ:ICCC	ImmuCell Corporation
2023/08/11	05:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ICCC	ImmuCell Corporation
2023/08/11	05:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ICCC	ImmuCell Corporation
2023/08/11	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICCC	ImmuCell Corporation
2023/08/11	05:05	GlobeNewswire Inc.	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023	NASDAQ:ICCC	ImmuCell Corporation
2023/08/08	01:00	GlobeNewswire Inc.	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023	NASDAQ:ICCC	ImmuCell Corporation
2023/07/21	22:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICCC	ImmuCell Corporation
2023/07/14	03:28	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ICCC	ImmuCell Corporation
2023/07/12	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICCC	ImmuCell Corporation